α-Hydroxybutyrate Is an Early Biomarker of Insulin Resistance and Glucose Intolerance in a Nondiabetic Population

PLoS ONE - Tập 5 Số 5 - Trang e10883
Walter Gall1, Kirk Beebe1, Kay A. Lawton1, Klaus‐Peter Adam1, Matthew Mitchell1, Pamela J. Nakhle1, John Ryals1, Michael V. Milburn1, Monica Nannipieri2, Stefania Camastra2, Andrea Natali2, Ele Ferrannini2
1Metabolon Incorporated, Research Triangle Park, North Carolina, United States of America.
2RISC (Relationship of Insulin Sensitivity to Cardiovascular Disease) Coordinating Office, Department of Internal Medicine, University of Pisa School of Medicine, Pisa, Italy

Tóm tắt

Từ khóa


Tài liệu tham khảo

H Ginsberg, 1974, Further evidence that insulin resistance exists in patients with chemical diabetes., Diabetes, 23, 674, 10.2337/diab.23.8.674

MI Harris, 1995, Epidemiologic studies on the pathogenesis of non-insulin-dependent diabetes mellitus (NIDDM)., Clin Invest Med, 18, 231

V Lyssenko, 2008, Clinical risk factors, DNA variants, and the development of type 2 diabetes., N Engl J Med, 359, 2220, 10.1056/NEJMoa0801869

GM Reaven, 1978, The role of insulin resistance in the pathogenesis of diabetes mellitus., Adv Metab Disord, 9, 313, 10.1016/B978-0-12-027309-6.50021-5

SW Shen, 1970, Comparison of impedance to insulin-mediated glucose uptake in normal subjects and in subjects with latent diabetes., J Clin Invest, 49, 2151, 10.1172/JCI106433

JH Warram, 1990, Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents., Ann Intern Med, 113, 909, 10.7326/0003-4819-113-12-909

RA DeFronzo, 1991, Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease., Diabetes Care, 14, 173, 10.2337/diacare.14.3.173

E Ferrannini, 2007, Insulin resistance, insulin response, and obesity as indicators of metabolic risk., J Clin Endocrinol Metab, 92, 2885, 10.1210/jc.2007-0334

HN Ginsberg, 2000, Insulin resistance and cardiovascular disease., J Clin Invest, 106, 453, 10.1172/JCI10762

G Howard, 1996, Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators., Circulation, 93, 1809

J Yip, 1998, Resistance to insulin-mediated glucose disposal as a predictor of cardiovascular disease., J Clin Endocrinol Metab, 83, 2773, 10.1210/jcem.83.8.5005

MA Abdul-Ghani, 2009, Pathophysiology of prediabetes., Curr Diab Rep, 9, 193, 10.1007/s11892-009-0032-7

RA Defronzo, 2009, Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus., Diabetes, 58, 773, 10.2337/db09-9028

GM Reaven, 1999, Insulin resistance: a chicken that has come to roost., Ann N Y Acad Sci, 892, 45, 10.1111/j.1749-6632.1999.tb07784.x

GM Reaven, 1983, Insulin secretion and action in noninsulin-dependent diabetes mellitus. Is insulin resistance secondary to hypoinsulinemia?, Am J Med, 75, 85, 10.1016/0002-9343(83)90258-9

RN Bergman, 2007, Orchestration of glucose homeostasis: from a small acorn to the California oak., Diabetes, 56, 1489, 10.2337/db07-9903

R Muniyappa, 2008, Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage., Am J Physiol Endocrinol Metab, 294, E15, 10.1152/ajpendo.00645.2007

KJ Boudonck, 2009, Discovery of metabolomics biomarkers for early detection of nephrotoxicity., Toxicol Pathol, 37, 280, 10.1177/0192623309332992

KA Lawton, 2008, Analysis of the adult human plasma metabolome., Pharmacogenomics, 9, 383, 10.2217/14622416.9.4.383

A Sreekumar, 2009, Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression., Nature, 457, 910, 10.1038/nature07762

TE Graham, 2006, Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects., N Engl J Med, 354, 2552, 10.1056/NEJMoa054862

SH Kim, 2008, Insulin resistance and hyperinsulinemia: you can't have one without the other., Diabetes Care, 31, 1433, 10.2337/dc08-0045

A Natali, 1997, Insulin sensitivity, vascular reactivity, and clamp-induced vasodilatation in essential hypertension., Circulation, 96, 849, 10.1161/01.CIR.96.3.849

MA Abdul-Ghani, 2007, Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test., Diabetes Care, 30, 89, 10.2337/dc06-1519

S Landaas, 1975, The formation of 2-hydroxybutyric acid in experimental animals., Clin Chim Acta, 58, 23, 10.1016/0009-8981(75)90481-7

SB Rosalki, 1960, Reduction of alpha-ketobutyrate by human serum., Nature, 188, 1110, 10.1038/1881110a0

JE Pettersen, 1973, The occurrence of 2-hydroxybutyric acid in urine from patients with lactic acidosis., Clin Chim Acta, 48, 213, 10.1016/0009-8981(73)90367-7

RS Lord, 2008, Clinical applications of urinary organic acids. Part I: Detoxification markers., Altern Med Rev, 13, 205

E Altmaier, 2008, Bioinformatics analysis of targeted metabolomics—uncovering old and new tales of diabetic mice under medication., Endocrinology, 149, 3478, 10.1210/en.2007-1747

EP Brass, 1986, Effect of alpha-ketobutyrate on palmitic acid and pyruvate metabolism in isolated rat hepatocytes., Biochim Biophys Acta, 888, 18, 10.1016/0167-4889(86)90065-0

S Landaas, 1975, Clinical conditions associated with urinary excretion of 2-hydroxybutyric acid., Scand J Clin Lab Invest, 35, 259, 10.3109/00365517509095738

RM Salek, 2007, A metabolomic comparison of urinary changes in type 2 diabetes in mouse, rat, and human., Physiol Genomics, 29, 99, 10.1152/physiolgenomics.00194.2006

AR Silva, 2001, Inhibition of in vitro CO2 production and lipid synthesis by 2-hydroxybutyric acid in rat brain., Braz J Med Biol Res, 34, 627, 10.1590/S0100-879X2001000500010

W Yang, 1985, Defect in alpha-ketobutyrate metabolism: a new inborn error., Clin Chim Acta, 145, 173, 10.1016/0009-8981(85)90284-0

G Paolisso, 1992, Glutathione infusion potentiates glucose-induced insulin secretion in aged patients with impaired glucose tolerance., Diabetes Care, 15, 1, 10.2337/diacare.15.1.1

CB Newgard, 2009, A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance., Cell Metab, 9, 311, 10.1016/j.cmet.2009.02.002

F Tremblay, 2007, Role of dietary proteins and amino acids in the pathogenesis of insulin resistance., Annu Rev Nutr, 27, 293, 10.1146/annurev.nutr.25.050304.092545

S Hills, 2004, The EGIR-RISC STUDY (The European Group for the Study of Insulin Resistance: relationship between insulin sensitivity and cardiovascular disease risk): I. Methodology and objectives., Diabetologia, 47, 566, 10.1007/s00125-004-1335-5

AM Evans, 2009, Integrated, Nontargeted Ultrahigh Performance Liquid Chromatography/Electrospray Ionization Tandem Mass Spectrometry Platform for the Identification and Relative Quantification of the Small-Molecule Complement of Biological Systems., Anal Chem

L Breiman, 2001, Random Forest., Machine Learning, 45, 5, 10.1023/A:1010933404324

A Liaw, 2002, Classification and Regression by random Forest., R News, 2, 18